Virtu Financial’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Virtu Financial’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-532	Closed	-$10K	–	2318
2022 Q2	$10K	Sell	532 -862	-62%	-$21.6K	﹤0.01%	1427
2022 Q1	$51K	Buy	1,394 +53	+4%	+$1.91K	﹤0.01%	1130
2021 Q4	$48K	Buy	1,341 +362	+37%	+$19.1K	﹤0.01%	1352
2021 Q3	$73K	Sell	979 -805	-45%	-$57.2K	0.01%	1213
2021 Q2	$156K	Buy	1,784 +183	+11%	+$17.4K	0.02%	1079
2021 Q1	$182K	Buy	+1,601	New	+$177K	0.01%	1121
2020 Q3	–	Sell	-486	Closed	-$39K	–	1602
2020 Q2	$39K	Buy	+486	New	+$44.5K	﹤0.01%	1041
2019 Q4	$19K	Sell	214 -296	-58%	-$27.6K	﹤0.01%	1330
2019 Q3	$53K	Buy	+510	New	+$110K	﹤0.01%	1185
2019 Q2	–	Sell	-385	Closed	-$179K	–	1944
2019 Q1	$179K	Buy	+385	New	+$150K	0.01%	1031
2018 Q4	–	Sell	-255	Closed	-$44K	–	2056
2018 Q3	$44K	Buy	+255	New	+$46.8K	﹤0.01%	1319

Other funds holding CSCI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Virtu Financial's CSCI Position: Q3 2022 in Review

Virtu Financial sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 532 shares — an estimated $10K sold.

Virtu Financial first reported a position in CSCI in Q3 2018 and held it in 11 quarters. The position peaked at $182K in Q1 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

Virtu Financial reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Virtu Financial sold 532 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $10K.
Virtu Financial first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2018 and held it in 11 quarters.
Virtu Financial's COSCIENS Biopharma Inc. Common Stock position peaked at $182K in Q1 2021.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.